All Blogs

Feb 12, 2025

Exploring the Current Alzheimer’s Disease Drug Development Pipeline


Apr 16, 2021

Ewing Sarcoma: Key Companies and Emerging Therapies in the Landscape


Apr 15, 2021

Lilly’s Retevmo shows promise; CeQur tanks up on $110M in funding; Repertoire secures $189M; Recursion sets terms for $306M IPO


Apr 14, 2021

Sleep Disorders: An Emerging Public Health Issue


Apr 13, 2021

Taysha Acquires Rare Disease Gene Therapy For $5.5 M; AZ’s Farxiga Fails In COVID-19 Study; Sanofi To Strengthen Its Vaccines Manufacturing Capacities


Apr 12, 2021

Alpha-1 Antitrypsin Deficiency: Symptoms, Treatments and Key Companies in the Market


Apr 09, 2021

Limited Therapeutics Options and A Weak Pipeline: What Lies Ahead in the Cancer Anorexia Market?


Apr 08, 2021

Artios collaborates with Novartis; Scholar Rock eyes Phase III trial; Novavax starts crossover arms in Covid-19 trials; Volastra nabs $44M


Apr 07, 2021

E-Pharmacies: A Disruptive Innovation and the Future of Pharma Sector


Apr 06, 2021

Cidara Therapeutics and J&J’s USD 780M Deal; FDA’s Approval to Supernus’s ADHD drug; Rain Therapeutics USD 100M IPO; NMPA Approval to Antengene’s ATG-019 IND Application